Patent 7560530 was granted and assigned to Schering on July, 2009 by the United States Patent and Trademark Office.
Provided herein are methods of modulating IL-33 activity, e.g., for the purpose of treating immune diseases and conditions, as well as methods of screening for compounds capable antagonizing IL-33 signaling.